We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$59.4M
AUM Growth
+$7.5M
Cap. Flow
+$6.24M
Cap. Flow %
10.51%
Top 10 Hldgs %
70.73%
Holding
35
New
8
Increased
7
Reduced
9
Closed
5

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$1.61M
2
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$1.61M
3
TSLA icon
Tesla
TSLA
+$1.49M
4
NVDA icon
NVIDIA
NVDA
+$1.45M
5
MOAT icon
VanEck Morningstar Wide Moat ETF
MOAT
+$1.45M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$1.41M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.34M
3
LLY icon
Eli Lilly
LLY
+$918K
4
NVO
Novo Nordisk
NVO
+$825K
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$683K

Sector Composition

Rank Sector Weight
1 Communication Services 26.04%
2 Technology 23%
3 Consumer Discretionary 20.07%
4 Healthcare 13.79%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
26
Alnylam Pharmaceuticals
ALNY
$38.3B
$570K 0.96%
3,221
-7,025
-69% -$1.34M
IOVA icon
27
Iovance Biotherapeutics
IOVA
$2.04B
$434K 0.73%
95,400
-1,100
-1% -$7.18K
ARBE icon
28
Arbe Robotics
ARBE
$73.3M
$79.4K 0.13%
33,512
– –
IPSC icon
29
Century Therapeutics
IPSC
$364M
$55.7K 0.09%
27,840
– –
FATE icon
30
Fate Therapeutics
FATE
$275M
$39.2K 0.07%
18,472
– –
BILL icon
31
BILL Holdings
BILL
$4.72B
– –
-4,300
Closed -$502K
DIS icon
32
Walt Disney
DIS
$171B
– –
-7,445
Closed -$665K
NVO
33
Novo Nordisk
NVO
$228B
– –
-10,200
Closed -$825K
SPGI icon
34
S&P Global
SPGI
$124B
– –
-3,513
Closed -$1.41M
XBI icon
35
State Street SPDR S&P Biotech ETF
XBI
$10B
– –
-8,200
Closed -$683K
1
2

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q3 2023 Portfolio in Review

As of Q3 2023, Parametrica Management held 35 positions worth $59.4M, up 14% from $51.9M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Parametrica Management deployed $6.24M of net new capital in Q3 2023, opening 8 new positions and adding to 7 existing holdings. Its largest new stake was Snowflake: 9,884 shares worth $1.51M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $1.34M trimmed.

  • Parametrica Management's largest Q3 2023 buy was Snowflake: 9,884 shares worth $1.51M.
  • Parametrica Management added most to Tesla in Q3 2023, an estimated $1.49M increase.
  • Parametrica Management's biggest Q3 2023 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
  • Parametrica Management fully exited S&P Global in Q3 2023, selling an estimated $1.41M.
  • Parametrica Management's ten largest holdings make up 71% of its $59.4M portfolio in Q3 2023.
  • Parametrica Management opened 8 new positions and closed 5 in Q3 2023.
  • Parametrica Management's portfolio value rose 14% quarter-over-quarter to $59.4M.

Based on Parametrica Management's 13F filing for Q3 2023, filed 31 Oct 2023.